TY -的盟Schapira玛丽莲·M AU - Chhatre Sumedha AU - Prigge,杰森M盟,獾的杰西卡盟——Kaminstein Dana AU -罗德里格斯,克里L AU - Fraenkel,藤本植物非盟- Kravetz表示,Jeffrey D AU -惠特尔杰夫AU -巴斯蒂安·罗莉盟——Vachani, Anil AU -埃克斯,斯科特AU - Schrand,苏珊•伊瓦拉盟——詹妮弗·V AU -峨山,偏向PY - 2022 DA - 2022/4/8 TI - Veteran-Centric网络决定肺癌筛查的援助:可用性分析乔- Res JMIR形式SP - e29039六世- 6 - 4 KW -肺癌筛查KW -决定援助KW -可用性KW -实现千瓦癌症筛查KW -共享决策千瓦退伍军人KW -病人接触KW -手机AB -背景:基于web的工具开发促进共享决策(SDM)过程可能促进肺癌筛查的实施(LCS),以证据为基础的干预,提高癌症的结果。退伍军人有特定的风险因素和共同的经验，影响LCS的好处和潜在的危害，因此可能重视以退伍军人为中心的LCS决策工具(LCSDecTool)。目的:本研究旨在对在退伍军人事务医疗中心接受护理的退伍军人设计的LCSDecTool进行可用性测试。方法:LCSDecTool的可用性测试分为原型版本(第一阶段)和高保真版本(第二阶段)，共有18名退伍军人和8名临床医生参加了第一阶段，43名退伍军人参加了第二阶段。来自用户的定量结果包括第一阶段的系统可用性量表(SUS)和最终用户计算满意度(EUCS)，第二阶段的SUS、EUCS和患者参与量表。定性数据从用户会话和简短访谈的观察中获得。第一阶段的结果为高保真版本的原型的修改提供了信息。第二阶段可用性测试是在第一类有效性-实施混合试验的背景下进行的。结果:在第一阶段原型可用性测试中，平均SUS得分(潜在范围:0-100)为81.90 (SD 9.80)，对应于优秀的可用性水平。 The mean EUCS score (potential range: 1-5) was 4.30 (SD 0.71). In the phase 2 high-fidelity usability testing, the mean SUS score was 65.76 (SD 15.23), corresponding to a good level of usability. The mean EUCS score was 3.91 (SD 0.95); and the mean Patient Engagement scale score (potential range 1 [low] to 5 [high]) was 4.62 (SD 0.67). The median time to completion in minutes was 13 (IQR 10-16). A thematic analysis of user statements documented during phase 2 high-fidelity usability testing identified the following themes: a low baseline level of awareness and knowledge about LCS increased after use of the LCSDecTool; users sought more detailed descriptions about the LCS process; the LCSDecTool was generally easy to use, but specific navigation challenges remained; some users noted difficulty understanding medical terms used in the LCSDecTool; and use of the tool evoked veterans’ struggles with prior attempts at smoking cessation. Conclusions: Our findings support the development and use of this eHealth technology in the primary care clinical setting as a way to engage veterans, inform them about a new cancer control screening test, and prepare them to participate in an SDM discussion with their provider. SN - 2561-326X UR - https://formative.www.mybigtv.com/2022/4/e29039 UR - https://doi.org/10.2196/29039 UR - http://www.ncbi.nlm.nih.gov/pubmed/35394433 DO - 10.2196/29039 ID - info:doi/10.2196/29039 ER -